Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
04/2014
04/16/2014CN102675567B Water-soluble degradable and efficiently antibacterial polymeric micelle and preparation method thereof
04/16/2014CN102652730B Ointment base, kuh-seng and green tea ointment and preparation method of ointment
04/16/2014CN102614491B Pharmaceutical composition containing echinocandin antifungal agent micafungin, its preparation method and application
04/16/2014CN102604149B Three-dimensional chitosan hydrogel and preparation method thereof
04/16/2014CN102579667B Preparation method of donkey-hide gelatin and Angelica blood-nourishing particles
04/16/2014CN102512400B Preparation method of efonidipine hydrochloride tablet
04/16/2014CN102481371B Sticky soft gel for treating poultry
04/16/2014CN102341166B Dispersion composition and manufacturing method therefor
04/16/2014CN102293829B Externally applying medicine for relieving pain and preparation method thereof
04/16/2014CN102227442B Cytotoxic t cell epitope peptide for sars coronavirus, and use thereof
04/16/2014CN102164606B Light-stabilized pharmaceutical composition
04/16/2014CN102091054B Progesterone preparation composite and preparation method thereof
04/16/2014CN101805343B Chemically modified small molecules
04/16/2014CN101642467B Long-acting disinfection paste
04/16/2014CN101366699B Novel lipid composition aerosol for controlled release of active pharmaceutical ingredient via inhalation
04/16/2014CN101291658B Compositions and methods for preparation of poorly water soluble drugs with increased stability
04/15/2014US8697756 Dimer diol compositions as substitutes of body fluids
04/15/2014US8697712 Presentation of an antiviral pharmaceutical composition
04/15/2014US8697650 HSA-related compositions and methods of use
04/15/2014US8697648 Protein agent for diabetes treatment and β cell imaging
04/15/2014US8697632 Amide based insulin prodrugs
04/15/2014US8697158 Mineral amino acid polysaccharide complex
04/15/2014US8697145 Substances having body mass redistribution properties
04/15/2014US8697138 Methods of using krill oil to treat risk factors for cardiovascular, metabolic, and inflammatory disorders
04/15/2014US8697137 Methods of using microspheres for active embolization
04/15/2014US8697115 Method of improving antioxidant status of an infant
04/15/2014US8697107 Flowable implant with crosslinkable surface membrane
04/15/2014US8697105 Injectable drug delivery formulation
04/15/2014US8697097 Stable solid preparations
04/15/2014US8697094 Stable solid preparations
04/15/2014US8697065 Non-natural ribonuclease conjugates as cytotoxic agents
04/15/2014US8697061 Tumor specific oligosaccharide epitopes and use thereof
04/15/2014US8697055 Probiotic, lactic acid-producing bacteria
04/15/2014US8697048 Peptide amphiphile suspension to prevent or reduce tumor formation from administered embryonic stem cells
04/15/2014US8697047 Stable immunogenic product comprising antigenic heterocomplexes
04/15/2014US8697045 Pegylated interleukin-10
04/15/2014US8697031 Dual function polymer micelles
04/15/2014CA2764134C Compositions and methods for preventing sternal wound infections
04/15/2014CA2597219C Contact drug delivery system
04/15/2014CA2544776C Polyethylene oxide-based films and drug delivery systems made therefrom
04/15/2014CA2525130C Improved cytotoxic agents comprising new maytansinoids
04/15/2014CA2469474C Potentiated topical compositions
04/12/2014CA2829650A1 Compositions and methods of forming films for improved drug delivery
04/10/2014WO2014055954A1 Progesterone containing oral dosage forms and kits
04/10/2014WO2014055893A1 Use of an ion exchange membrane to remove impurities from cell-binding agent cytotoxic agent conjugates
04/10/2014WO2014055846A1 Conductive polymer graphene oxide composite materials
04/10/2014WO2014055754A1 Conformationally-constrained kinked endosomal-disrupting peptides
04/10/2014WO2014055740A1 Controlled release solid dose forms
04/10/2014WO2014055738A1 Controlled release solid dose forms
04/10/2014WO2014055539A1 Nanoparticle emulsions
04/10/2014WO2014055515A1 Use of p3 of bacteriophage fusion proteins as amyloid binding agents
04/10/2014WO2014055397A1 Tablet containing composite with cyclodextrin
04/10/2014WO2014055338A1 Decubitus treatment system
04/10/2014WO2014055253A1 Methods of synthesizing and using peg-like fluorochromes
04/10/2014WO2014054702A1 Hydrogel-forming material, premix, and hydrogel formation method
04/10/2014WO2014054699A1 Hydrogel-forming material
04/10/2014WO2014054693A1 Treatment agent and cosmetic material, containing co-modified organopolysiloxane
04/10/2014WO2014054651A1 Sleep-improving agent, non-rem sleep time-increasing agent, and sedative agent
04/10/2014WO2014054588A1 Nanogel/exosome complex and dds
04/10/2014WO2014054026A1 Liposomal drug delivery system
04/10/2014WO2014053882A1 Cell penetrating peptides for intracellular delivery of molecules
04/10/2014WO2014053881A1 Cell penetrating peptides for intracellular delivery of molecules
04/10/2014WO2014053880A1 Cell penetrating peptides for intracellular delivery of molecules
04/10/2014WO2014053879A1 Cell penetrating peptides for intracellular delivery of molecules
04/10/2014WO2014053873A1 Polymeric prodrug conjugates
04/10/2014WO2014053654A1 Polymer synthesis
04/10/2014WO2014053629A1 Cell penetrating peptides for intracellular delivery of molecules
04/10/2014WO2014053628A1 Cell penetrating peptides for intracellular delivery of molecules
04/10/2014WO2014053624A1 Cell penetrating peptides for intracellular delivery of molecules
04/10/2014WO2014053622A1 Cell penetrating peptides for intracellular delivery of molecules
04/10/2014WO2014053555A1 Veterinary drug system
04/10/2014WO2014053521A2 Nonlinear saccharide conjugates
04/10/2014WO2014053262A1 Composition, in particular a pharmaceutical composition, in particular for administration in hoarseness
04/10/2014WO2014053245A1 Hydroxylated polyamine derivatives as transfection reagents
04/10/2014WO2013188864A4 Anti-cd22 anti-idiotypic antibodies and uses thereof
04/10/2014WO2013155173A3 Methods and compositions relating to biodegradable epoxy elastomers
04/10/2014WO2013132485A9 Polymers having therapeutically active agents conjugated thereto, processes of preparing same and uses thereof
04/10/2014US20140100411 Treatment of cardiovascular disorders with targeted nanoparticles
04/10/2014US20140100292 Use of moisture-conditioned disintegrants or expanding agents in tablet manufacture for the selective adjustment of the mechanical properties, the dissolving kinetics and/or the water loading of the tablets
04/10/2014US20140100291 Actinically-Crosslinkable Siloxane-Containing Copolymers
04/10/2014US20140100285 Compositions of percutaneous administration of physiologically active agents
04/10/2014US20140100282 Intranasal administration of pharmaceutical agents for treatment of neurological diseases
04/10/2014US20140100269 Oral cannabinoid formulations
04/10/2014US20140100256 Formulations of enzalutamide
04/10/2014US20140100252 Amorphous ritonavir co-precipitated
04/10/2014US20140100236 Use of selectively moisture-adjusted tabletting material in the production of mechanically stable tablets which contain at least one hydrate-forming active substance and/or adjuvant relevant to the mechanical stability of the tablets, particularly arginine-containing tablets
04/10/2014US20140100190 Use of lipid conjugates in cystic fibrosis and applications thereof
04/10/2014US20140100183 Central administration of stable formulations of therapeutic agents for cns conditions
04/10/2014US20140100180 Topical pharmaceutical composition based on semifluorinated alkanes
04/10/2014US20140100178 Composition and methods for site-specific drug delivery to treat malaria and other liver diseases
04/10/2014US20140100172 Cancer Imaging and Treatment
04/10/2014US20140100163 Non-peptide agonists and antagonists of adrenomedullin and gastrin releasing peptide
04/10/2014US20140100161 System and Method for Multiphasic Release of Growth Factors
04/10/2014US20140100154 Prodrugs of Peptide Epoxy Ketone Protease Inhibitors
04/10/2014US20140099506 Biodegradable Polymers with Sulfenamide Bonds for Drug Delivery Applications
04/10/2014US20140099426 Natural coating formulas and composition for coating tablets
04/10/2014US20140099382 Treatment using dantrolene
04/10/2014US20140099370 Controlled release of biologically active compounds
04/10/2014US20140099369 Tamper-resistant oral opioid agonist formulations
04/10/2014US20140099366 Composition Containing Two Anti-Dementia Drugs
1 ... 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 ... 1712